Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+16.5%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+16.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$31.63M+70.7%
2024$18.53M-3.1%
2023$19.13M-4.3%
2022$19.99M+248.2%
2021$5.74M-
2020$0.00-